An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Completed · Phase 3

Conditions studied: Idiopathic Parkinson's Disease

In brief

The objective of this open-label extension is to assess the safety and tolerability of long-term treatment of rotigotine in subjects with idiopathic PD.

Key facts

Study ID

NCT00505687

Run by

UCB Pharma

People needed

186

Starts

2005-02-01

Expected to finish

2008-12-01

Last updated by the study team

2014-10-02

Who can join

Age: 31 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have completed treatment in one of the SP824 (NCT00242008), SP825 (NCT00243971), or SP826 (NCT00243945) trials

You may not qualify if…

• Subjects who had an ongoing serious adverse event from the previous OLE trial that was assessed as related to study medication

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Fort Wayne, Indiana, United States
• Study site — Southfield, Michigan, United States
• Study site — Forest Hills, New York, United States
• Study site — Asheville, North Carolina, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Houston, Texas, United States
• Study site — Milwaukee, Wisconsin, United States
• Study site — Innsbruck, Austria
• Study site — Bochum, Germany
• Study site — Dresden, Germany
• Study site — Kassel, Germany
• Study site — Ulm, Germany
• Study site — Tel Aviv, Israel
• Study site — Ancona, Italy
• Study site — Lucca, Italy
• Study site — Messina, Italy
• Study site — Pretoria, Gauteng, South Africa
• Study site — Parow, Western Cape, South Africa
• Study site — Plumstead, Western Cape, South Africa
• Study site — Barcelona, Spain
• Study site — Barncose Terrace, Redruth, United Kingdom
• Study site — Bridgend, United Kingdom
• Study site — North Shields, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.